Effect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro

Journal of Controlled Release

Volumn 42, Issue 1, 1996, Pages 57-64

  Ganga, S ^a   Ramarao, P ^b   Singh, J ^c  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Azone; Human epidermis; Iontophoresis; Metoprolol tartrate; Transdermal

Indexed keywords

LAUROCAPRAM; METOPROLOL TARTRATE;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IONTOPHORESIS; MALE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030272493     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01351-X     Document Type: Article

References (40)

1. [1] P. Tyle, Iontophoretic devices for drug delivery. Pharm. Res. 3 (1986) 318-326.
2. [2] M.S. Roberts, J. Singh, N. Yoshida and K.I. Currie, Iontophoretic transport of selected solutes through human epidermis, in: R.C. Scott, J. Hadgraft and R. Guy (Eds.), Prediction of Percutaneous Absorption, IBC Technical Service Ltd., London, 1989, pp. 231-241.
3. [3] M.R. Lark and L.P. Gangarosa, Iontophoresis an effective modality for the treatment of inflammatory disorders of the temporomandibular joint and myofascial pain, J. Craniomandib. Pract. 8 (1990) 108-119.
4. [4] C.L. Gay, P.G. Green, R.H. Guy and M.L. Francoeur, Iontophoretic delivery of piroxicam across the skin in-vitro, J. Control. Rel. 22 (1992) 57-68.
5. [5] S.K. Gupta, S. Kumar, S. Bolton, C.R. Behl and A.W. Mallick, Optimization of iontophoretic transdermal delivery of a peptide and a nonpeptide drug delivery. J. Control. Rel. 30 (1994) 253-261.
6. [6] R.V. Padmanabhan, J.B. Phipps, G.A. Lattin and R.J. Sawchuk, In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J. Control. Rel. 11 (1990) 123-135.
7. [7] T. Tsuji, Bleomycin: Iontophoretic therapy for verrucous carcinoma, Arch. Dermatol. 127 (1991) 973-975.
8. [8] T.J. Petelenz, J.A. Buttke, C. Bonds, L.B. Lloyd, J.E. Beck, R.L. Stephen, S.C. Jacobsen and P. Rodriguez, Iontophoresis of dexamathasone: lab studies, J. Control. Rel. 20 (1992) 55-56.
9. [9] Y. Sun, H. Xue, H. Gu and J. Zhang. Rapid drug absorption following transdermal iontophoresis, Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 19 (1992) 479-480.
10. [10] V. Srinivasan, M.H. Su, W.I. Higuchi and C.R. Behl, Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin, J. Pharm. Sci. 79 (1990) 588-591.
11. [11] L. Wearley and Y.W. Chien, Enhancement of the in-vitro skin permeability of Azidothymidine (AZT) via iontophoresis and chemical enhancers, Pharm. Res. 7 (1990) 34-40.
12. [12] S. Singh, Ph.D Thesis, Passive and iontophoretic delivery of some model drugs through human skin. Banaras Hindu University, Varanasi, India, 1991.
13. [13] W.H.M.C. Hinsberg, H.E. Bodde, C.J. Verhoef, L.J. Bax and H.E. Junginger, Effect of dodecyl Azone on skin resistance and iontophoretic peptide flux using two skin models: human and shed snake skin, Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 19 (1992) 483-484.
14. [14] J. Hirvonen, L. Murtomaki, K. Konturri, P. Paronen and A. Uttri, Transdermal permeation of model anions and cations: Effect of skin charge, iontophoresis and penetration enhancers, Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 19 (1992) 452-453.
15. [15] U.T. Lashmar and J. Manger, Investigations into the potential for iontophoresis facilitated transdermal delivery of acyclovir, Int. J. Pharm. 111 (1994) 73-82.
16. [16] Martindale The Extra Pharmacopoeia (29th Eds.) London Pharmaceutical Press, 1989, pp. 791-792.
17. [17] J.R. Luch, Metoprofol Tartrate, in: K. Florey (Eds.), Analytical Profiles of Drug Substances, Vol 12, Academic Press, USA, 1983, pp. 325-386.
18. [18] Y. Morimoto, K. Sugibayashi, K. Hosoya and W.I. Higuchi, Penetration enhancing effect of Azone on the transport of 5-fluorouracil across hairless rat skin, Int. J. Pharm. 32 (1986) 31-38.
19. [19] A.M. Kligman and E. Christophers, Preparation of isolated sheets of human statum corneum. Arch. Dermatol. 88 (1963) 702-710.
20. [20] J. Swarbrick, G. Lee and J. Brom, Drug permeation through human skin. I. Effect of storage conditions of skin, J. Invest. Derm. 78 (1982) 63-66.
21. [21] R.P.R. Dawber, R. Marks and J.A. Swift, Scanning electron microscopy of the stratum corneum, Br. J. Derm. 86 (1972) 272-281.
22. [22] R. Marks and R.P.R. Dawber, Skin surface biopsy: An improved technique for the examination of the horny layer, Br. J. Derm. 84 (1971) 117-123.
23. [23] J.P. Carteud, Scanning electron microscopy in skin pathology, in: Scanning Electron Microscopy: Proceedings of the workshop on scanning electron microscopy in pathology (IIT Research Institute, Chicago, Illinois, USA, 1973) 3 pp. 629-635.
24. [24] L. Wearley, Jue-Chen Liu and Y.W. Chien, Iontophoresis facilitated transdermal delivery of verapamil. II. Factors affecting the reversibility of skin permeability, J. Control. Rel. 9 (1989) 231-281.
25. [25] B.J. Aungst, N.J. Rogers and E. Shefter, Enhancement of naloxone penetration through human skin in-vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides, Int. J. Pharm. 33 (1986) 225-234.
26. [26] B.W. Barry and S.L. Bennet, Effect of penetration enhancers on the permeation of mannitol hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39 (1987) 535-546.
27. [27] P.M. Elias, Epidermal lipids, barrier function and desquamation, J. Invest. Dermatol. 80 Suppl. (1983) 44-49.
28. [28] A. Hoelgaard, B. Mollguard and E. Baker, Vehicle effect on topical drug delivery. IV. Effect of N-methylpyrrolidone and polar lipids on percutaneous drug transport, Int. J. Pharm. 43 (1988) 233-240.
29. [29] B.W. Barry, Penetration enhancers: Mode of action in human skin, in: B. Shroot and H. Schaefer (Eds.), Skin Pharmacokinetics., Karger, Basel, 6, 1987, pp. 121-137.
30. [30] M. Goodman and B.W. Barry. Differential scanning calorimetry of human stratum corneum: effect of Azone, J. Pharm. Pharmacol. 37 Suppl. (1985) 80P.
31. [31] J.C. Beastall, J. Hadgraft and C. Washington, Mechanism of action of Azone as a percutaneous penetration enhancer: lipid bilayer fluidity and transition temperature effects, Int. J. Pharm. 43 (1988) 207-213.
32. [32] J. Bouwstra, L. Peschier, J. Brusse and H. Bodde, Effect of n-alkyl azocycloheptanan-2-ones including Azone on the thermal behaviour of human stratum corneum, Int. J. Pharm. 52 (1989) 47-54.
33. [33] P.P. Bhatt, J.H. Rytting and E.M. Topp, Influence of Azone and lauryl alcohol on the transport of acetaminophen and ibuprofen through shed snake skin, Int. J. Pharm. 72 (1991) 219-226.
34. [34] J. Bouwstra, M. DeVries, G. Gooris, W. Bras, J. Brusse and M. Porrec, Thermodynamic and stuctural aspects of the skin barrier, J. Control. Rel. 15 (1991) 209-220.
35. [35] F. Schuckler and G. Lee, Relating the concentration dependent effect of Azone and dodecyl-ℒ-pyroglutamate to change in drug diffusivity, partition coeffient and flux, Int. J. Pharm. 80 (1992) 81-89.
36. [36] B.B. Michniak, M.R. Player, J.M. Chapman Jr. and J.W. Sowell Sr., In-vitro evaluation of a series of Azone analogs as dermal penetration enhancers, Int. J. Pharm. 91 (1993) 85-93.
37. [37] B.B. Michniak, M.R. Player, J.M. Chapman Jr. and J.W. Sowell Sr., Azone analogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention, J. Control. Rel. 32 (1994) 147-154.
38. [38] T. Ogiso, M. Iwaki, K. Bechako and Y. Tsutsumi, Enhancement of percutaneous absorption by laurocapram, J. Pharm. Sci. 81 (1992) 762-767.
39. [39] K. Sugibayashi, S. Nakayama, T. Seki, K. Hosoya and Y. Morimoto, Mechanism of skin penetration enhancing effect by laurocapram, J. Pharm. Sci. 81 (1992) 58-64.
40. [40] R.B. Stoughton and W.O. McClure, Azone: A new nontoxic enhancer of cutaneous penetration. Drug. Dev. Ind. Pharm. 9 (1983) 725-744.